Company Filing History:
Years Active: 2021-2022
Title: Innovations of Peter Boross in Antibody Development
Introduction
Peter Boross is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on enhancing the characteristics of CD20 antibodies, which are crucial in therapeutic applications.
Latest Patents
Peter Boross holds a patent for CD20 antibodies with improved characteristics. This patent describes antibodies that comprise a mouse IgG2, a human IgG1, IgA1, or IgA2 constant region, and a variable domain capable of binding the epitope 'EPANpSEK' (SEQ ID NO:31) on human CD20 expressed on Ramos cells. Notably, these antibodies exhibit increased PCD functionality when compared to Rituximab with a constant region of the same isotype. He has 1 patent to his name.
Career Highlights
Peter is associated with Tiga Tx, Inc., where he continues to innovate in the field of antibody research. His work is pivotal in advancing therapeutic options for various diseases, particularly in oncology.
Collaborations
Peter collaborates with esteemed colleagues such as Jeannette Henrica Wilhelmina Leusen and Johannes Hendrik Marco Jansen. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Peter Boross is a prominent figure in the field of antibody development, with a focus on improving CD20 antibodies. His innovative work and collaborations are paving the way for advancements in therapeutic applications.